Grifols, S.A. - stock earnings
GRFS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 63.0 million USD | 1.7 billion USD |
| 2023Q2 | 65.3 million USD | 1.8 billion USD |
| 2023Q1 | 21.9 million USD | 1.9 billion USD |
| 2022Q4 | 21.5 million USD | 1.8 billion USD |
| 2022Q3 | 43.7 million USD | 1.5 billion USD |
| 2022Q2 | 94.5 million USD | 1.6 billion USD |
| 2022Q1 | -208.4 million USD | 1.0 billion USD |
| 2021Q4 | -42.0 million USD | 1.2 billion USD |
| 2021Q3 | -42.0 million USD | 1.2 billion USD |
| 2021Q2 | 162.3 million USD | 1.6 billion USD |
| 2021Q1 | 261.8 million USD | 1.5 billion USD |
| 2020Q4 | 272.0 million USD | 1.6 billion USD |
| 2020Q3 | 313.7 million USD | 1.6 billion USD |
| 2020Q2 | 35.8 million USD | 1.6 billion USD |
| 2020Q1 | 222.5 million USD | 1.5 billion USD |
| 2019Q4 | 226.0 million USD | 1.5 billion USD |
| 2019Q3 | 149.4 million USD | 1.4 billion USD |
| 2019Q2 | 196.2 million USD | 1.4 billion USD |
| 2019Q1 | 144.1 million USD | 1.4 billion USD |
| 2018Q4 | 146.8 million USD | 1.4 billion USD |
| 2018Q3 | 173.8 million USD | 1.3 billion USD |
| 2018Q2 | 203.0 million USD | 1.3 billion USD |
| 2018Q1 | 284.1 million USD | 1.3 billion USD |
| 2017Q4 | 275.8 million USD | 1.3 billion USD |
| 2017Q3 | 181.3 million USD | 1.2 billion USD |
| 2017Q2 | 164.6 million USD | 1.3 billion USD |
| 2017Q1 | 148.9 million USD | 1.2 billion USD |
| 2016Q4 | 146.6 million USD | 1.2 billion USD |
| 2016Q3 | 158.9 million USD | 1.1 billion USD |
| 2016Q2 | 154.9 million USD | 1.1 billion USD |
| 2016Q1 | 148.0 million USD | 1.2 billion USD |
| 2015Q4 | 142.7 million USD | 1.2 billion USD |
| 2015Q3 | 157.7 million USD | 1.1 billion USD |
| 2015Q2 | 149.3 million USD | 1.1 billion USD |
| 2015Q1 | 142.2 million USD | 993.4 million USD |
| 2014Q4 | 159.6 million USD | 1.1 billion USD |
| 2014Q3 | 144.9 million USD | 1.0 billion USD |
| 2014Q2 | 141.7 million USD | 1.1 billion USD |
| 2014Q1 | 108.0 million USD | 956.0 million USD |
| 2013Q4 | 108.4 million USD | 960.0 million USD |
| 2013Q3 | 113.7 million USD | 898.4 million USD |
| 2013Q2 | 119.7 million USD | 908.8 million USD |
| 2013Q1 | 76.1 million USD | 847.7 million USD |
| 2012Q4 | 78.3 million USD | 872.5 million USD |
| 2012Q3 | 82.4 million USD | 830.1 million USD |
| 2012Q2 | 82.1 million USD | 808.7 million USD |
| 2012Q1 | 89.9 million USD | 887.6 million USD |
| 2011Q4 | 8.4 million USD | 764.5 million USD |
| 2011Q3 | 33.3 million USD | 774.7 million USD |
| 2011Q2 | -20.8 million USD | 541.4 million USD |
| 2011Q1 | 26.1 million USD | 355.7 million USD |
| 2010Q4 | 24.6 million USD | 335.1 million USD |
| 2010Q3 | 41.7 million USD | 263.2 million USD |
| 2010Q2 | 99.8 million USD | 733.3 million USD |
| 2009Q4 | 303.8 million USD | 1.9 billion USD |
GRFS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 25.9 million USD | 7.2 billion USD |
| 2022 | 223.5 million USD | 6.5 billion USD |
| 2021 | 301.8 million USD | 5.6 billion USD |
| 2020 | 753.3 million USD | 6.5 billion USD |
| 2019 | 700.3 million USD | 5.7 billion USD |
| 2018 | 682.6 million USD | 5.1 billion USD |
| 2017 | 791.4 million USD | 5.2 billion USD |
| 2016 | 573.9 million USD | 4.3 billion USD |
| 2015 | 581.8 million USD | 4.3 billion USD |
| 2014 | 571.9 million USD | 4.1 billion USD |
| 2013 | 477.2 million USD | 3.8 billion USD |
| 2012 | 338.6 million USD | 3.5 billion USD |
| 2011 | 65.2 million USD | 2.3 billion USD |
| 2010 | 153.6 million USD | 1.3 billion USD |
| 2009 | 212.0 million USD | 1.3 billion USD |
| 2008 | 169.6 million USD | 1.1 billion USD |
| 2007 | 128.2 million USD | 1.0 billion USD |
| 2006 | 59.9 million USD | 856.3 million USD |
| 2005 | 30.3 million USD | 620.8 million USD |
GRFS
Price: $6.57
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.10 USD
P/E Ratio: 212.50
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 924384
Ebitda: 362.6 millionMarket Capitalization: 5.6 billion
Average Dividend Frequency: 2